Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1093 | 971 | 1093 | 995 | 1511 | 2508 |
Fund Return | 9.31% | -2.87% | 9.31% | -0.17% | 8.61% | 9.63% |
Place in category | 455 | 524 | 455 | 208 | 190 | 131 |
% in Category | 84 | 94 | 84 | 45 | 42 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Harbor Capital Appreciation Instl | 17.92B | 30.46 | 7.70 | 16.00 | ||
Harbor Capital Appreciation Retirem | 10.58B | 30.57 | 7.78 | - | ||
Harbor International Institutional | 2.57B | 4.23 | 1.43 | 4.22 | ||
Harbor Small Cap Value Instl | 1.85B | 10.93 | 4.91 | 8.91 | ||
Harbor Capital Appreciation Inv | 1.03B | 29.99 | 7.31 | 15.58 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Explorer Adm | 18.94B | 10.37 | 0.56 | 10.22 | ||
Vanguard Small Cap Growth Index Adm | 14.63B | 16.49 | 0.42 | 9.09 | ||
Neuberger Berman Genesis R6 | 4.8B | 9.31 | 0.84 | 9.80 | ||
T. Rowe Price Instl Small-Cap Stock | 4.6B | 11.75 | 0.25 | 9.78 | ||
T. Rowe Price QM US Small-Cap Gr Eq | 4.65B | 13.06 | 2.15 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Ascendis Pharma AS | US04351P1012 | 4.26 | 127.55 | -0.46% | |
Comfort Systems | US1999081045 | 3.26 | 523.22 | +3.86% | |
Vaxcyte | US92243G1085 | 2.82 | 87.79 | +2.91% | |
ITT | US45073V1089 | 2.64 | 152.66 | +0.98% | |
Casella | US1474481041 | 2.49 | 111.82 | +0.30% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Sell | Strong Buy |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review